Incretin

From WikiMD.org
Jump to navigation Jump to search

Incretin

Incretin (/ɪnˈkrɛtɪn/) is a group of metabolic hormones that stimulate a decrease in blood glucose levels. Incretins are released after eating and augment the secretion of insulin released from pancreatic beta cells of the islets of Langerhans by a blood glucose-dependent mechanism.

Etymology

The term "incretin" is derived from "INtestinal seCRETion of INsulin". It was first used in the 1930s to describe the increased insulin secretion caused by oral glucose that could not be explained by the amount of glucose alone.

Types of Incretins

There are two main types of incretins: Glucagon-like peptide-1 (GLP-1) and Glucose-dependent insulinotropic polypeptide (GIP). Both hormones work to enhance the body's release of insulin following a meal, which helps to lower blood glucose levels.

Incretin Effect

The incretin effect refers to the phenomenon where oral ingestion of glucose leads to a higher insulin response when compared to intravenous glucose administration. This effect is largely due to the hormones GLP-1 and GIP.

Related Terms

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski